← Back to Search

Behavioral Intervention

Single-Session Intervention to Promote Hope for Domestic Violence

N/A

Waitlist Available

Led By Tami Sullivan, PhD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Self-identify as a woman (cis- or trans-gender woman)

Currently in a relationship of at least 3 months duration in which they have experienced physical IPV by a male partner

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to one month

Awards & highlights

Study Summary

This trial aims to create a short self-guided session to help increase hope among women who are experiencing intimate partner violence. The study will have two stages: developing the intervention and testing it. This registration

Who is the study for?

This trial is for women who are experiencing intimate partner violence (IPV). It aims to help them develop or increase feelings of hope. Participants should be interested in a self-guided, one-time session designed to improve their emotional wellbeing.Check my eligibility

What is being tested?

The study is testing a brief, self-guided single-session intervention (SSI) focused on fostering hope. The pilot stage will assess how feasible and safe the SSI is, and if it's liked by participants. It also looks at its effect on hope, self-worth, empowerment, and overall emotional health.See study design

What are the potential side effects?

Since this intervention involves psychological support without medications or medical procedures, there may not be physical side effects. Emotional discomfort could arise when discussing sensitive topics like IPV.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I identify as a woman.

Select...

I have been in a relationship for 3+ months and experienced physical abuse from a male partner.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (pre intervention) and up to one month (post intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (pre intervention) and up to one month (post intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre intervention) and up to one month (post intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability/likability assessed using the Program Feeback Scale

Change in Hope assessed using Beck Hopelessness Scale (single item)

Change in Hope assessed using Herth Hope Index

+5 more

Secondary outcome measures

Change in Emotional wellbeing measured by the Patient Health Questionnaire-2 (PHQ-2)

Change in Emotional wellbeing measured by the State Joy Scale

Change in Empowerment assessed using The Personal Progress Scale-Revised (PPS-R)

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single-Session Intervention to Promote HopeExperimental Treatment1 Intervention

A 30-45 minute self-guided intervention delivered in a web browser.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,854 Previous Clinical Trials

2,740,496 Total Patients Enrolled

Office on Violence Against Women (OVW)UNKNOWN

Tami Sullivan, PhDPrincipal InvestigatorDepartment of Psychiatry, Yale School of Medicine

1 Previous Clinical Trials

666 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still eligible to enroll in this ongoing clinical trial?

"As per the details available on clinicaltrials.gov, recruitment for this trial is currently closed. The study was initially listed on 4/1/2024 and last revised on 4/16/2024. While this particular trial is not actively seeking participants, it's worth noting that there are 22 other trials currently open for enrollment."

Answered by AI

What is the primary objective that this medical study aims to achieve?

"The main goal of this research is to evaluate the feasibility based on the percentage of participants enrolled. Additional objectives include examining changes in empowerment using The Personal Progress Scale-Revised (PPS-R), which involves daily assessment through two items scored from 0 (Strongly Disagree) to 5 (Strongly Agree). Scores are totaled, ranging from 0-10 with higher scores reflecting increased empowerment levels. Furthermore, emotional well-being alterations will be evaluated via the Patient Health Questionnaire-2 (PHQ-2), measuring depressive symptoms prevalence through a scale ranging from 0 (Not at all) to 3 (Nearly the entire day"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Single Session Intervention to Promote Hope

2024. "Single Session Intervention to Promote Hope". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06375876.

All > Domestic Violence